Science and Research
Scientific research is a vital and strategically important part of Masaryk Memorial Cancer Institute activities. It is statutorily embedded in MMCI regulations. Moreover, research is one of the main activities for which our organization was established. Thus, MMCI a unique center in the Czech Republic which hosts under one roof both basic and applied research in the field of oncology and related biomedical fields. MMCI has its own research facility, and it also participates in numerous domestic and international cooperation projects.
1Focus of science and research
The MMCI scientific program focuses on seven key topics:
- Precision oncology in the field of prevention, diagnosis, surgical, radiation, and pharmacologic cancer treatment
- Translational research in molecular oncology and genetics
- Immune system and cancer
- Social sciences and humanities
- Supporting expert systems in oncology
- Cancer prevention
- Project connectivity in EU
2Direction of Science and Research
- Independent researchers (introduced in the attachment) covering basic, translational, as well as clinical research provide feedback on research at MMCI, discuss relevant indicators of further development, and recommend a strategy for further advancement.
- The Division of Science, Research, and Education at MMCI has two advisory bodies, the Scientific Board (which meets twice a year) and the Clinical Research Council (which meets regularly once a month). The Division comprises several independent units, the Bank of Biological Material, Research Centre for Applied Molecular Oncology (RECAMO), National Project Support Office, International Project Support Office, Medical Information Office, and, last but not least, the activities of the Scientific Secretary.
3Contacts
You can send us your requests and questions in the field of research
E [obfuscate_1_|117|112|113|107|109|108|55|100|111|109|45|90|113]
Management →
Director for Science, Research and Education
doc. MUDr. Tomáš Kazda, Ph.D.Staff →
Director of Research Centre for Applied Molecular Oncology (RECAMO)
RNDr. Bořivoj Vojtěšek, DrSc.
Executive Director of the Bank of Biological Material
doc. Mgr. Roman Hrstka, Ph.D.
Scientific Secretary
prof. RNDr. Ondřej Slabý, Ph.D.
Head of National Project Support Office
Ing. Zuzana Kuncová
Head of the International Project Support Office
Ing. Iva Mládenková, Ph.D.
Head of Medical Information Office
Ing. Zlatuše Křístková4RECAMO
The Research Centre for Applied Molecular Oncology (RECAMO) is a modern research institute focusing on cancer biology.
5Bank of Biological Material
The Bank of Biological Material (BBM) stores long-term frozen tissues or tissues processed otherwise, along with other human biological material from MMCI cancer patients. These samples, along with relevant clinical information, are primarily used for research projects.
6 Scientific Secretary
The Scientific Secretary shall ensure the organization and management of the Scientific Board. They participate in organizing scientific work and develop new strategies and concepts for the advancement of science and research at MMCI.
Scientific Secretary →
7Scientific Board
The Scientific Board advises the Director on matters concerning science and research conducted at MMCI, including conceptual and strategic direction. It discusses and provides opinions primarily on projects carried out within the framework of grant support, including those financed by institutional support.
Topics discussed at the spring meeting →
- Information on IPO for the given year (presentation of overall drawing plan).
- Presentation of projects financed from IPO for the given year.
- Presentation of final reports and evaluation of projects financed by an external grant agency, the implementation of which was completed in the previous year (individual presentations of individual researchers / co-researchers).
- Presentation of new projects funded by external grant agencies.
- Presentation of current academic studies taking place in MMCI.
- MMCI publication activity in the previous year.
Topics discussed at the autumn meeting →
- Progress of IPO projects implementation. Presentation of final results of projects that were financed from IPO (including individual presentations of researchers in case of completed PPVs).
- Presentation of new projects funded by external grant agencies.
- Analysis of unsuccessful applications to external grant competitions in the previous year.
- Projects of doctoral studies/educations.
- Information on status of projects in RECAMO, BBMRI and other projects.
- Plan for IPO drawing for the following year.
Members of the Scientific Board 2024 →
Ing. et Ing. Jan Adam, Ph.D.
Department of Nuclear Medicine, MMCI, Researcher
doc. MUDr. Oldřich Coufal, Ph.D.
Department of Breast, Skin and Oncoplastic Surgery, MMCI, Medical Chief of the Department
doc. MUDr. Regina Demlová, Ph.D.
Department of Clinical Trials, MMCI, Medical chief of the Department
doc. MUDr. Jan Doležel, Ph.D.
Department of Urologic Oncology, MMCI, Physician
prof. RNDr. Ladislav Dušek, Ph.D.
Institute of Health Information and Statistics of the Czech Republic, Director
Mgr. Jakub Dvořáček, MHA, LL.M.
Ministry of Health of the Czech Republic, Director for the Czech Presidency
doc. MUDr. Vuk Fait, CSc.
Department of Surgical Oncology, MMCI, Head of the Department
doc. MUDr. Lenka Foretová, Ph.D.
Department of Cancer Epidemiology and Genetics, MMCI, Medical Chief of the Department
doc. MUDr. Marián Hajdúch, Ph.D.
Institute of Molecular and Translational Medicine, Palacky University Olomouc, Director of the Institute
MUDr. Jana Halámková, Ph.D.
Department of Comprehensive Cancer Care, Cancer Prevention Center, MMCI, Head of the Center
prof. MUDr. Markéta Hermanová, Ph.D.
1st Department of Pathology, St. Anne´s University Hospital Brno, Head of the Department
prof. Ing. Lenka Hernychová, Ph.D.
Research Centre for Applied Molecular Oncology (RECAMO), MMCI, Head of Research Group
doc. Mgr. Roman Hrstka, Ph.D.
Research Centre for Applied Molecular Oncology (RECAMO), MMCI, Head of Research Group
Bank of Biological Material, MMCI, Executive Director
prof. MUDr. Zdeněk Kala, CSc.
Department of Surgery, University Hospital Brno, Head of the Department
doc. MUDr. Igor Kiss, Ph.D., MBA
Division of Medical Care, MMCI, Director for Medical Care
Department of Comprehensive Cancer Care, MMCI, Head of the Department
prof. RNDr. Jana Klánová, Ph.D.
RECETOX, Faculty of Sciences, Masaryk University, Director of RECETOX
MUDr. Rudolf Nenutil, CSc.
Department of Pathology, MMCI, Pathologist
doc. MUDr. Radka Lordick Obermannová, Ph.D.
Phase One Trial Unit, Department of Comprehensive Cancer Care, MMCI, Medical Chief of the Unit
prof. RNDr. Šárka Pospíšilová, Ph.D.
CEITEC MUNI, Centre for Molecular Medicine, Head of the Centre
prof. RNDr. Ondřej Slabý, Ph.D.
CEITEC MUNI, Head of Research Group
Department of Biology, Medical Faculty, Masaryk University, Head of the Department
Scientific Secretary, MMCI
prof. MUDr. Martin Smrčka, Ph.D., MBA
Clinic of Neurosurgery, University Hospital Brno, Head of the Department
University Hospital Brno, Director for Science, Research and Education
doc. MUDr. Michal Staník, Ph.D.
Department of Urologic Oncology, MMCI, Medical Chief of the Department
doc. PhDr. Miroslav Světlák, Ph.D.
Department of Medical Psychology and Psychosomatics, Medial Faculty, Masaryk University, Head of the Department
prof. MUDr. Marek Svoboda, Ph.D.
Masaryk Memorial Cancer Institute, Director
doc. Mgr. Jiří Šána, Ph.D.
CEITEC, Masaryk University, Researcher
prof. MUDr. Aleksi Šedo, DrSc.
Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Head of the Institute
prof. MUDr. Pavel Šlampa, CSc.
Department of Radiation Oncology, MMCI, Head of the Department
prof. MUDr. Radek Špíšek, Ph.D.
Institute of Immunology, Sedond Faculty of Medicine, Charles University
prof. MUDr. Jaroslav Štěrba, Ph.D.
Department of children's oncology, University Hospital Brno, Head of the Department
RNDr. Bořivoj Vojtěšek, DrSc.
Research Centre for Applied Molecular Oncology (RECAMO), MMCI, Head of Research Group, Scientific Director of RECAMO
prof. MUDr Jan Žaloudík, CSc.
Department of Surgical Oncology, MMCI, Physician
Emeritus Members:
RNDr. Ludmila Lauerová, CSc.
RNDr. Marta Šimíčková, CSc.
MUDr. Tačo Tačev, CSc.
prof. MUDr Rostislav Vyzula, CSc.
8Clinical Research Council
The MMCI Clinical Research Council (hereinafter referred to as the CRC) is a body under the Director for Science and Research, established to support the development of MMCI's scientific research activities, internal coordination, registration, and supervision of these activities.
Activities of the Clinical Research Council →
- It sets priorities in the field of applied research and proposes internal rules dealing with the implementation of these projects to MMCI management,
- discusses interim and final reports on the progress of research, development and educational projects and outputs from internal and external inspections of these projects and proposes possible measures to MMCI management,
- sets priorities for transfer of knowledge from research to clinical practice and for the development of laboratory examination methods.
Dates of the Clinical Research Council meetings in 2024 →
|
|---|
9International Project Support Office
It provides consultancy and methodological guidance in the preparation of new scientific research projects under international grant schemes, particularly the Horizon Europe program and other EU community programs. The main activity of the unit primarily involves providing information and administrative support in the preparation of project applications and the actual process of their submission. Subsequent support and the implementation of the project are ensured in close cooperation and collaboration with the scientific team, legal, economic, and human resources departments.
Management →
Head of International Project Support Office
Ing. Iva Mládenková, Ph.D.
10National Project Support Office
It provides consultancy and methodological guidance in the preparation of new scientific research projects for domestic grant schemes. It offers consultancy and administrative support during the application process and throughout the execution of research projects.
Management →
Head of National Project Support Office
Ing. Zuzana Kuncová11Medical Information Office
The Medical Information Office is responsible for collecting, compiling, controlling, and storing data on cancer in the Czech Republic. It is also responsible for storing compiled and validated data in the National Oncological Register (NOR) database. Through its activities, the Medical Information Office participates in creating and maintaining the national NOR database, managed by the Institute of Health Information and Statistics of the Czech Republic (IHIS CR). The aggregated data from the NOR database serve as the basis not only for cancer epidemiology but also for evaluating, organizing, and managing cancer healthcare. The knowledge and experience gained from cancer registration are applied by the Medical Information Office to create and develop parametric health documentation within MMCI's information system.
Management →
Head of Medical Information Office
Ing. Zlatuše KřístkováStaff →
13MMCI grants
MMCI is actively involved in research, education, and development projects. Further information about grants can be found in the Czech version in the downloadable files.
Science and Research
Free Cancer Helpline
Monday – Friday from 7.30 AM to 3.00 PM
(+420)800 222 322